Canonical ingredient
Cyclosporine
CYCLOSPORINE
29 linked products
Official identifiers
Names and synonyms
- Cyclosporine (en)
- Cyclosporine (fr)
- Cyclosporine A (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl human health priority
- High
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- Yes
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Equivalent concepts in other registries
These links require an exact shared identifier; names alone are never sufficient.
- cyclosporin A
GLOBAL · CAS 59865-13-3
Verification source
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
APO-CYCLOSPORINE ORAL SOLUTION
100 · MG · ML
ATOPICA
10 · MG
ATOPICA
25 · MG
ATOPICA
50 · MG
ATOPICA
100 · MG
ATOPICA FOR CATS
100 · MG · ML
CEQUA
0.09 · % · W/V
CYCLOSPORINE
25 · MG
CYCLOSPORINE
25 · MG
CYCLOSPORINE
100 · MG
CYCLOSPORINE
50 · MG
NEORAL
50 · MG
NEORAL
100 · MG
NEORAL
25 · MG
NEORAL
100 · MG · ML
NEORAL
10 · MG
OPTIMMUNE
2 · MG · G
RESTASIS
0.05 · % · W/V
RESTASIS MULTIDOSE
0.05 · % · W/V
SANDIMMUNE CAP 50MG
50 · MG
SANDIMMUNE I.V.
50 · MG · ML
SANDIMMUNE ORAL SOL 100MG/ML
100 · MG · ML
SANDIMMUNE SOFT GELATIN CAP 100MG
100 · MG
SANDIMMUNE SOFT GELATINE CAP 25MG
25 · MG
SANDOZ CYCLOSPORINE
100 · MG
SANDOZ CYCLOSPORINE
25 · MG
SANDOZ CYCLOSPORINE
50 · MG
TEVA-CYCLOSPORINE
0.05 · % · W/V
VERKAZIA
0.1 · % · W/V